106 3.2.1. Caractéristiques sociodémographiques, p.106 ,
Acute and long-term treatment of mania, Dialogues Clin Neurosci, vol.10, issue.2, pp.165-79, 2008. ,
Pharmacotherapy of Bipolar Disorder with Quetiapine: A Recent Literature Review and an Update, Clinical Psychopharmacology and Neuroscience, vol.13, issue.1, pp.25-35, 2015. ,
DOI : 10.9758/cpn.2015.13.1.25
Psycho-pharmacologie et médicaments psychiatriques, Acquis Médicales Récent, pp.195-207, 1957. ,
New atypical antipsychotic medications, Journal of Psychiatric Research, vol.32, issue.3-4, pp.3-4215, 1998. ,
DOI : 10.1016/S0022-3956(98)00023-5
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry, pp.789-96, 1988. ,
Summary of the comparative effectiveness review on offlabel use of atypical antipsychotics, J Manag Care Pharm JMCP. 2012, vol.18, issue.5, pp.1-20 ,
Practice guideline for the treatment of patients with bipolar disorder (revision), Am J Psychiatry, vol.159, issue.4, pp.1-50, 2002. ,
American Psychiatric Association Guideline Watch: Practice guideline for the treatment of patients with bipolar disorder, Am J Psychiatry, 2005. ,
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder, The World Journal of Biological Psychiatry, vol.16, issue.9, 2013. ,
DOI : 10.1192/bjp.133.5.429
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013, Bipolar Disorders, vol.131, issue.Suppl. 1, 2013. ,
DOI : 10.1111/bdi.12025
Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology, Journal of Psychopharmacology, vol.23, issue.4, pp.346-88, 2009. ,
DOI : 10.1177/0269881109102919
Clinical practice recommendations for bipolar disorder, Acta Psychiatrica Scandinavica, vol.2, issue.s434, pp.27-46, 2009. ,
DOI : 10.1111/j.1600-0447.2009.01383.x
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression, World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry, 2010. ,
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders, The World Journal of Biological Psychiatry, vol.34, issue.3, pp.334-85, 2013. ,
DOI : 10.1126/science.1121613
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015, The World Journal of Biological Psychiatry, vol.182, issue.2, pp.76-95, 2015. ,
DOI : 10.1016/j.jad.2009.06.044
Quetiapine: novel uses in the treatment of depressive and anxiety disorders, Expert Opinion on Investigational Drugs, vol.12, issue.35, pp.1187-204, 2010. ,
DOI : 10.4088/JCP.09m05284yel
Psychopharmacologie essentielle (4° Éd.) : Bases neuroscientifiques et applications pratiques, LAVOISIER, 2016. ,
Pharmacologie et mode d'action des neuroleptiques, EMC, pp.37-860, 2005. ,
Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorder, The International Journal of Neuropsychopharmacology, vol.14, issue.01, pp.131-173, 2011. ,
DOI : 10.1017/S146114571000101X
A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder, The Journal of Clinical Psychiatry, vol.66, issue.01, 2005. ,
DOI : 10.4088/JCP.v66n0116
A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression, American Journal of Psychiatry, vol.162, issue.7, pp.1351-60, 2005. ,
DOI : 10.1176/appi.ajp.162.7.1351
Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium, Journal of Affective Disorders, vol.191, pp.256-73, 2016. ,
DOI : 10.1016/j.jad.2015.11.002
Trial 144 Study Investigators. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder, Trial, vol.144 ,
Weight gain, obesity, and metabolic indices following a first manic episode: Prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM), Journal of Affective Disorders, vol.124, issue.1-2, pp.108-125, 2010. ,
DOI : 10.1016/j.jad.2009.10.023
The Effects of Atypical Antipsychotic Drugs on Neurocognitive Impairment in Schizophrenia: A Review and Meta-analysis, Schizophrenia Bulletin, vol.25, issue.2 ,
DOI : 10.1093/oxfordjournals.schbul.a033374
A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up study, European Psychiatry, vol.31, pp.201620-201628 ,
DOI : 10.1016/j.eurpsy.2015.09.460
Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients. Compr Psychiatry, pp.613-635, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00663897
Les médicaments psychotropes : les thymorégulateurs. Lavoisier, 2013. ,
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis, The Lancet, vol.382, issue.9896, pp.951-62, 2013. ,
DOI : 10.1016/S0140-6736(13)60733-3
Screening and management of bipolar disorders: results]. L'Encéphale, pp.86-102, 2010. ,
Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study, Current Medical Research and Opinion, vol.24, issue.1, pp.1-10, 2008. ,
DOI : 10.1185/030079908X253933
A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry, pp.305-318, 2006. ,
Single-blind Comparison of Rapid Dose Administration of Divalproex ER Versus Quetiapine in Patients with Acute Bipolar Mania, Innov Clin Neurosci, vol.8, issue.1, p.29, 2011. ,
Quetiapine or haloperidol as monotherapy for bipolar mania???a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial, European Neuropsychopharmacology, vol.15, issue.5, pp.573-85, 2005. ,
DOI : 10.1016/j.euroneuro.2005.02.006
Extended-Release Quetiapine as Monotherapy for the Treatment of Adults With Acute Mania: A Randomized, Double-Blind, 3-Week Trial, Clinical Therapeutics, vol.33, issue.11, pp.1643-58, 2011. ,
DOI : 10.1016/j.clinthera.2011.10.002
Efficacy and Safety of Quetiapine in Children and Adolescents With Mania Associated With Bipolar I Disorder, The Journal of Clinical Psychiatry, vol.74, issue.01, 2013. ,
DOI : 10.4088/JCP.11m07424
Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies, Current Medical Research and Opinion, vol.21, issue.6, pp.923-957, 2005. ,
DOI : 10.1185/030079905X46340
Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis, The Lancet, vol.378, issue.9799, pp.1306-1321, 2011. ,
DOI : 10.1016/S0140-6736(11)60873-8
Efficacy of antimanic treatments: metaanalysis of randomized, controlled trials. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol, pp.375-89, 2011. ,
A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry, pp.1216-1239, 2002. ,
A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania, International Clinical Psychopharmacology, vol.22, issue.4, 2007. ,
DOI : 10.1097/YIC.0b013e328080ca57
Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study, International Journal of Bipolar Disorders, vol.133, issue.3, p.14, 2014. ,
DOI : 10.1186/s40345-014-0014-9
Rapid titration versus conventional titration of quetiapine in the treatment of bipolar mania: a preliminary trial, International Clinical Psychopharmacology, vol.20, issue.6, pp.327-357, 2005. ,
DOI : 10.1097/00004850-200511000-00008
First controlled treatment trial of bipolar II hypomania with mixed symptoms: Quetiapine versus placebo, Journal of Affective Disorders, vol.150, issue.1, pp.37-43, 2013. ,
DOI : 10.1016/j.jad.2013.02.031
Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy, Acta Psychiatrica Scandinavica, vol.31, issue.3, pp.12-20, 2007. ,
DOI : 10.1097/00004714-200004000-00012
Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder, J Clin Psychiatry, vol.69, pp.9-15, 2008. ,
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder, Archives of General Psychiatry, vol.59, issue.6, pp.530-537, 2002. ,
DOI : 10.1001/archpsyc.59.6.530
Bipolar Depression: Overview and Commentary, Harvard Review of Psychiatry, vol.18, issue.3, pp.143-57, 2010. ,
DOI : 10.3109/10673221003747955
Efficacy of Quetiapine Monotherapy for the Treatment of Depressive Episodes in Bipolar I Disorder, The Journal of Clinical Psychiatry, vol.69, issue.5, pp.769-82, 2008. ,
DOI : 10.4088/JCP.v69n0510
Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression, Archives of General Psychiatry, vol.60, issue.11, pp.1079-88, 2003. ,
DOI : 10.1001/archpsyc.60.11.1079
Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression, Journal of Affective Disorders, vol.121, issue.1-2, pp.1-2106, 2010. ,
DOI : 10.1016/j.jad.2009.10.007
A doubleblind , placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I), J Clin Psychiatry, 2010. ,
A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II), The Journal of Clinical Psychiatry, vol.71, issue.02, pp.163-74, 2010. ,
DOI : 10.4088/JCP.08m04942gre
Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression, Journal of Affective Disorders, vol.157, pp.33-40 ,
DOI : 10.1016/j.jad.2013.12.032
Treatments for Acute Bipolar Depression: Meta-analyses of Placebo-controlled, Monotherapy Trials of Anticonvulsants, Lithium and Antipsychotics, Pharmacopsychiatry, vol.47, issue.02, pp.43-52, 2014. ,
DOI : 10.1055/s-0033-1363258
Lamotrigine plus quetiapine combination therapy in treatment-resistant bipolar depression, Ann Clin Psychiatry Off J Am Acad Clin Psychiatr. Feb, vol.23, issue.1, pp.17-24, 2011. ,
Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression ,
Lancet Psychiatry, pp.31-40, 2016. ,
Quetiapine for acute bipolar depression: a systematic review and meta-analysis, Drug Design, Development and Therapy, vol.8, pp.827-865, 2014. ,
DOI : 10.2147/DDDT.S63779
Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study, Journal of Affective Disorders, vol.76, issue.1-3, pp.1-3267, 2003. ,
DOI : 10.1016/S0165-0327(02)00075-7
Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): A pragmatic trial of complex treatment for a complex disorder, Clinical Trials, vol.64, issue.1, pp.114-141, 2014. ,
DOI : 10.1056/NEJMoa0806994
Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records, World Psychiatry, vol.386, issue.1, pp.53-61, 2016. ,
DOI : 10.1002/wps.20298
Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.27, issue.5, 2003. ,
DOI : 10.1016/S0278-5846(03)00145-3
Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network, International Clinical Psychopharmacology, vol.22, issue.6, 2007. ,
DOI : 10.1097/YIC.0b013e3281c55f63
Combination quetiapine therapy in the long-term treatment of patients with bipolar I disorder, Clinical Practice and Epidemiology in Mental Health, vol.1, issue.1, p.7, 2005. ,
DOI : 10.1186/1745-0179-1-7
Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: A 4-year follow-up naturalistic study, Journal of Affective Disorders, vol.110, issue.1-2, pp.135-176, 2008. ,
DOI : 10.1016/j.jad.2008.01.017
Effectiveness of quetiapine plus lamotrigine maintenance therapy in challenging bipolar disorder patients, Journal of Affective Disorders, vol.137, issue.1-3, pp.1-3139, 2012. ,
DOI : 10.1016/j.jad.2011.12.024
Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126), Journal of Affective Disorders, vol.109, issue.3, pp.251-63, 2008. ,
DOI : 10.1016/j.jad.2008.06.001
Maintenance Treatment for Patients With Bipolar I Disorder: Results From a North American Study of Quetiapine in Combination With Lithium or Divalproex (Trial 127), Trial 127 Investigators, pp.476-88, 2009. ,
DOI : 10.1176/appi.ajp.2008.08020189
Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials. Depress Anxiety, 2013. ,
Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder, J Affect Disord, vol.142, pp.1-336, 2012. ,
Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials, The International Journal of Neuropsychopharmacology, vol.14, issue.08, pp.1029-1078, 2011. ,
DOI : 10.1017/S1461145711000885
Abstract, CNS Spectrums, vol.10, issue.06, pp.299-313, 2009. ,
DOI : 10.1016/j.euroneuro.2007.07.005
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study???, Journal of Affective Disorders, vol.128, issue.1-2, pp.83-94, 2011. ,
DOI : 10.1016/j.jad.2010.06.031
double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder, Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry, 2013. ,
Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.70, issue.4, pp.526-565, 2009. ,
DOI : 10.4088/JCP.08m04592
Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials, BMC Psychiatry, vol.23, issue.6, p.160, 2012. ,
DOI : 10.1097/YIC.0b013e328306a987
Second-generation antipsychotics for major depressive disorder and dysthymia, Cochrane Database Syst Rev, vol.38, issue.5, p.8121, 2010. ,
DOI : 10.1002/14651858.CD008121.pub2
How to define treatment-resistant depression?]. Presse Médicale Paris Fr 1983, pp.354-363, 2016. ,
Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.70, issue.4, pp.540-549, 2009. ,
DOI : 10.4088/JCP.08m04629
Extendedrelease quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study, Int J Neuropsychopharmacol Off Sci J Coll Int Neuropsychopharmacol CINP, 2010. ,
Evaluation of adjunct extendedrelease quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy, Int J Neuropsychopharmacol Off Sci J Coll Int Neuropsychopharmacol CINP, 2013. ,
Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study, Depression and Anxiety, vol.8, issue.7 ,
DOI : 10.1002/da.20275
Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study ,
Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials, American Journal of Psychiatry, vol.166, issue.9, pp.980-91, 2009. ,
DOI : 10.1176/appi.ajp.2009.09030312
Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder, Brazilian Journal of Medical and Biological Research, vol.47, issue.7, pp.605-621, 2014. ,
DOI : 10.1590/1414-431X20143672
Quetiapine augmentation of treatment-resistant depression: a comparison with lithium, Current Medical Research and Opinion, vol.23, issue.2, pp.333-374, 2007. ,
DOI : 10.1185/030079906X162809
Comparative Efficacy, Acceptability, and Tolerability of Augmentation Agents in Treatment-Resistant Depression, The Journal of Clinical Psychiatry, 2015. ,
DOI : 10.4088/JCP.14r09204
Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder, Journal of Affective Disorders, vol.151, issue.1, pp.209-228, 2013. ,
DOI : 10.1016/j.jad.2013.05.079
A systematic review and meta-analysis of the evidence base for add-on treatment for patients with major depressive disorder who have not responded to antidepressant treatment: A European perspective, Journal of Psychopharmacology, vol.162, issue.2, pp.85-98, 2014. ,
DOI : 10.1016/j.euroneuro.2011.07.018
Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial, Depression and Anxiety, vol.193, issue.10, pp.964-76, 2010. ,
DOI : 10.1002/da.20740
Potentiation strategies]. Presse Médicale Paris Fr 1983, pp.333-377, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01482633
Who are patients suffering from bipolar disorders in France? The TEMPPO survey: patients' sociodemographic and clinical characteristics data]. L'Encéphale, pp.211-234, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00712619
Treatment practices in the management of patients with bipolar disorder in France. The TEMPPO study]. L'Encéphale, Feb, vol.38, issue.1, pp.75-85, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00689013
Therapeutic management of bipolar disorder in France and Europe: a multinational longitudinal study (WAVE-bd)]. L'Encéphale, pp.392-400, 2014. ,
Prescribing of antipsychotics in UK primary care: a cohort study, BMJ Open, vol.71, issue.12, p.6135, 2014. ,
DOI : 10.1136/bmjopen-2014-006135
The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders?, Journal of Affective Disorders, vol.73, issue.1-2, pp.19-32, 2003. ,
DOI : 10.1016/S0165-0327(02)00324-5
Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants, Bipolar Disorders, vol.100, issue.1, pp.465-70, 2005. ,
DOI : 10.1097/01.PSY.0000073871.67679.D8
Comorbidity between bipolar disorder and borderline personality disorder: Prevalence, explanatory theories, and clinical impact, Journal of Affective Disorders, vol.202, pp.210-219, 2016. ,
DOI : 10.1016/j.jad.2016.05.048
Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990???2015: Systematic review and meta-analysis, Journal of Affective Disorders, vol.206, 2009. ,
DOI : 10.1016/j.jad.2016.07.011
Early and late onset bipolar disorders: two different forms of manic-depressive illness?, Journal of Affective Disorders, vol.58, issue.3, pp.215-236, 2000. ,
DOI : 10.1016/S0165-0327(99)00111-1